期刊文献+

HPLC法测定氟康唑在早孕妇女胚胎和血液中的浓度 被引量:1

Embryo tissue and plasma concentration of fluconazole in pregnant women assayed by HPLC
下载PDF
导出
摘要 目的建立早孕妇女血和胚胎组织中氟康唑浓度测定的RP-HPLC法。方法血和胚胎组织样品采用1 mol·L^(-1) NaOH溶液碱化、乙酸乙酯萃取后行HPLC测定。色谱柱:Diamonsil^(TM)C_(18)(200 mm×4.6 mm,5μm),流动相:乙腈-0.03 mol·L^(-1)磷酸盐缓冲液(pH 5.8,25:75,V/V),流速1.2 mL·min^(-1);检测波长260 nm;柱温40℃。结果血、胚胎组织样品分别在0.2~10 mg·L^(-1)和0.133~6.667μg·g^(-1)浓度范围内线性良好,最低检测浓度分别为0.1 mg·L^(-1)和0.066 7μg·g^(-1),方法回收率为96.56~104.35%,日内RSD≤6.81%,日间RSD≤4.78%,血和胚胎组织中氟康唑的萃取回收率均>70%。结论此法能简便、灵敏、准确地测定早孕妇女血和胚胎组织中氟康唑的浓度,可用于临床药动学研究。 AIM To develop a reversed phase HPLC method for the determination of fluconazole level in pregnant women plasma and embryo tissue. METHODS The plasma and embryo tissue samples were alkalinized with 1 mol· L^- 1 NaOH and extracted with acetoacetate. Chromatographic separation was achieved at 40℃; on a Diamonsil^TM C18 ( 200 mm × 4.6 mm, 5 μm) analytical column. The mobile phase was acetonitrile - 0.03 mol· L^-1 phosphate buffer solution (pH 5.8,25:75, V/V). The flow rate was 1.2 mL·min^-1. UV detection was set at 260 nm. RESULTS The linear range of fluconazole was 0.2 - 10 mg·L^-1 and 0. 133 - 6.667 μg·g^-1 and the detection limits were 0.1 mg·L^-1 and 0.066 7 μg· g^-1 for plasma and embryo tissue samples, respectively. Method recovery was 96.56% - 104.35%. Intraand inter-day variations were less than 6.81% and 4.78%, respectively. The extraction recoveries of fluconazole from plasma and tissue homogenates were more than 70%. CONCLUSION The established method is a simple, sensitive and accurate means for determining fluconazole level in pregnant women plasma and embryo tissue, and it is suitable for clinical phamaacokinetic studies.
出处 《中国临床药学杂志》 CAS 2008年第1期44-47,共4页 Chinese Journal of Clinical Pharmacy
基金 深圳市福田区科技局(FT200518号)资助
关键词 氟康唑 高效液相色谱 胚胎组织 血浆 fluconazole HPLC embryo tissues plasma
  • 相关文献

参考文献8

  • 1Gilles RG, Moni F. Infections diseases in obstetrics and gynecology [M]. 4th ed. Omaha. USA: IDI publications, 1999: 464. 被引量:1
  • 2王正容,罗丽娅,刘萍,钱文璟.氟康唑对妊娠妇女的生殖毒性研究进展[J].中南药学,2005,3(4):235-237. 被引量:4
  • 3Jick SS. Pregnancy outcomes after maternal exposure to fluconazole[J]. Pharmacotherapy, 1999, 19 (2): 221. 被引量:1
  • 4Sorensen HT, Nielsen GL, Olesen C, et al. Risk of malformations and other otltcomes in children exposed to fluconazole in utero[J]. Br J Clin Pharmacol, 1999, 48 (2): 234. 被引量:1
  • 5Momes LA, Lerner FE, Moraes ME, et al. Fluconazole bioequivalence study: quantification by tandem mass spectrometry [ J ]. Ther Drug Monit, 1999, 21(2):200. 被引量:1
  • 6Wattananat T, Akarawut W. Validated HPLC method for the determination of fluconazole in human plasma[J]. Biomed Chromatogr, 2006, 20 (1):1. 被引量:1
  • 7Kim SS, Im HT, Kang IM, et al. An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study [J]. J Ohromatogr B Analyt Technol Biomed Life Sci, 2007, 852(1 - 2) : 174. 被引量:1
  • 8王小林,季颖,江志强,黄君,施荟.氟康唑胶囊的人体生物等效性评价[J].中国临床药学杂志,2003,12(5):280-283. 被引量:18

二级参考文献22

  • 1王浴生,洪诤,郭平,李章万,强文安.氟康唑的药物动力学和生物利用度的研究[J].中国抗生素杂志,1995,20(4):297-301. 被引量:1
  • 2[1]Gilles RG,Moni F.Infections diseases in obstetrics and gynecology.4th ed.Omaha[C].USA:IDI publications,1999.464 被引量:1
  • 3[2]Drouhet E,Dupon B.Evolution of antifungal agents:past,present and future[J].Rev Infect Dis,1987,99(suppl 1):84 被引量:1
  • 4[7]Lee BE,Feinberg M,Abraham JJ,et al.Congenital malformations in an infant born to a women treated with fluconazole[J].Pediatr Infect Dis J,1992,11(12):1062 被引量:1
  • 5[8]Pursley TJ,Blomquist JK,Abraham JJ,et al.Fluconazole-induced congenital anomalies in three infants[J].Clin Infect Dis,1996,22(2):336 被引量:1
  • 6[9]Aleek KA,Bartley DL.Multiple malformation syndrome following fluconazole use in pregnancy:report of an additional patient[J].Am J Med Genet,1997,72(3):253 被引量:1
  • 7[10]Krcmery S,Masar O,Krcmery V Jr.Nosocomial Torulopsis glabrata fungemia with shock in a pregnant woman successfully treated with high doses of fluconazole and delivery of healthy child[J].J Chemother,1995,7(3):253 被引量:1
  • 8[11]Tiboni GM.Second brachial arch anomalies induced by fluconazole,a bis-triazole antifungal agent,in cultured mouse embryos[J].Res Commun Chem Pathol Pharmacol,1993,79(4):381 被引量:1
  • 9[12]Inman W,Pearee G,Wilton L.Safety of fluconazole in the treatment of vaginal candidiasis:a prescription-event monitoring study,with special reference to the outcome of pregnancy[J].Eur J Clin Pharmacol,1994,46(2):115 被引量:1
  • 10[13]Mastroiacovo P,Mazzone T,Botto LD,et al.Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole[J].Am J Obstet Gynecol,1996,175(6):1645 被引量:1

共引文献19

同被引文献12

  • 1王正容,罗丽娅,刘萍,钱文璟.氟康唑对妊娠妇女的生殖毒性研究进展[J].中南药学,2005,3(4):235-237. 被引量:4
  • 2Tiboni GM.Second brachial arch anomalies induced by fluconazole,a his-triazole antifungal agent,in cultured mouse embryos[J].Res Commun Chem Pathol Pharmacol,1993,79(2):381-384. 被引量:1
  • 3Inman W,Pearee G,Wilton L.Safety of fluconazole in the treatment of vaginal candidiasis:a prescription-event monitoring study,with special reference to the outcome of pregnancy[J].Eur J Clin Pharmacol,1994,46(5):115-118. 被引量:1
  • 4Mastroiacovo P,Mazzone T,Eotto LD,et al.Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole[J].Am J Obstet Gynecol,1996,175(6):1645-1650. 被引量:1
  • 5Jick SS.Pregnancy outcomes after maternal exposure to fluconazole[J].Pharmacotherapy,1999,19(2):221-222. 被引量:1
  • 6Henrik TR,Gunnar LN,Charlotte O,et al.Risk of malformations and other outcomes in children exposed to fluconazole in utero[J].British Journal of Clinical Pharmacology,1999,48(2):234. 被引量:1
  • 7Lee BE,Feinberg M,Abraham JJ,et al.Congenital malformations in an infant born to a women treated with fluconazole[J].Pediatr Infect Dis J,1992,11(3):1062-1064. 被引量:1
  • 8Pursley TJ,Blomquist JK,Abraham JJ,et al.Fluconazole-induced congenital anomalies in three infants[J].Clin Infect Dis,1996,22(8):336-340. 被引量:1
  • 9Aleek KA,Bartley DL.Multiple malformation syndrome following fluconazole use in pregnancy:report of an additional patient[J].Am J Med Genet,1997,72(9):253-256. 被引量:1
  • 10李中,赵新波,陈兆军.药代动力学参数估算方法概述[J].中国医药导报,2009,6(13):8-10. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部